scPharmaceuticals | 8-K:重大事件
scPharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-J. Luther King, Jr.(5.8%),Luther King Capital Management Corporation(5.5%)
scPharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Lundbeckfond Invest A/S (“Lundbeckfond”)(5.7%),Lene Skole (“Skole”)(5.7%)
scPharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Laurence W. Lytton(5.9%)
scPharmaceuticals | 10-Q:2024财年三季报
scPharmaceuticals | 8-K:重大事件
scPharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-J. Luther King, Jr.(4.6%),Luther King Capital Management Corporation(4.5%)
scPharmaceuticals | 4:持股变动声明-董事 SCHAEFFER LEONARD D
scPharmaceuticals | 4/A:持股变动声明(修正)-高管 Nokes Rachael
scPharmaceuticals | 4:持股变动声明-股东 ORBIMED ADVISORS LLC
scPharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-OrbiMed Advisors LLC(12.1%),OrbiMed Capital GP VI LLC(11.6%)等
scPharmaceuticals | 8-K:重大事件
scPharmaceuticals | 10-Q:2024财年二季报
scPharmaceuticals | 8-K:重大事件
scPharmaceuticals | 424B5:募资说明书
scPharmaceuticals | 424B5:募资说明书
scPharmaceuticals | 8-K:重大事件
scPharmaceuticals | 4:持股变动声明-高管 Nokes Rachael
scPharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-J. Luther King, Jr.(6.4%),Luther King Capital Management Corporation(6.1%)
scPharmaceuticals | 8-K:重大事件
暂无数据